Loss of forebrain MTCH2 decreases mitochondria motility and calcium handling and impairs hippocampal-dependent cognitive functions

Mitochondrial Carrier Homolog 2 (MTCH2) is a novel regulator of mitochondria metabolism, which was recently associated with Alzheimer’s disease. Here we demonstrate that deletion of forebrain MTCH2 increases mitochondria and whole-body energy metabolism, increases locomotor activity, but impairs mot...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Ruggiero, Antonella, Aloni, Etay, Korkotian, Eduard, Zaltsman, Yehudit, Oni-Biton, Efrat, Kuperman, Yael, Tsoory, Michael, Shachnai, Liat, Levin-Zaidman, Smadar, Brenner, Ori, Segal, Menahem, Gross, Atan
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5343590/
https://ncbi.nlm.nih.gov/pubmed/28276496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep44401
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars